{"id":"https://openalex.org/W4245225751","doi":"https://doi.org/10.2337/figshare.13100045","title":"HbA1c Change and Diabetic Retinopathy During GLP-1 Receptor Agonist Cardiovascular Outcome Trials: A Meta-analysis and Meta-regression","display_name":"HbA1c Change and Diabetic Retinopathy During GLP-1 Receptor Agonist Cardiovascular Outcome Trials: A Meta-analysis and Meta-regression","publication_year":2020,"publication_date":"2020-12-21","ids":{"openalex":"https://openalex.org/W4245225751","doi":"https://doi.org/10.2337/figshare.13100045"},"language":"en","primary_location":{"id":"doi:10.2337/figshare.13100045","doi":"https://doi.org/10.2337/figshare.13100045","is_oa":true,"landing_page_url":"https://doi.org/10.2337/figshare.13100045","pdf_url":"https://diabetesjournals.figshare.com/articles/figure/HbA1c_Change_and_Diabetic_Retinopathy_During_GLP-1_Receptor_Agonist_Cardiovascular_Outcome_Trials_A_Meta-analysis_and_Meta-regression/13100045/1/files/25108103.pdf","source":null,"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://diabetesjournals.figshare.com/articles/figure/HbA1c_Change_and_Diabetic_Retinopathy_During_GLP-1_Receptor_Agonist_Cardiovascular_Outcome_Trials_A_Meta-analysis_and_Meta-regression/13100045/1/files/25108103.pdf","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065924611","display_name":"Mary Angelyn Bethel","orcid":"https://orcid.org/0000-0002-7754-6584","observed_orcids":["https://orcid.org/0000-0002-7754-6584"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Angelyn Bethel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013408607","display_name":"Rafael D\u00edaz","orcid":"https://orcid.org/0000-0003-2181-9579","observed_orcids":["https://orcid.org/0000-0003-2181-9579"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rafael Diaz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038764606","display_name":"Noelia Castellana","orcid":"https://orcid.org/0009-0005-2937-0835","observed_orcids":["https://orcid.org/0009-0005-2937-0835"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Noelia Castellana","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101620095","display_name":"Indranil Bhattacharya","orcid":"https://orcid.org/0000-0001-9268-6844","observed_orcids":["https://orcid.org/0000-0001-9268-6844"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Indranil Bhattacharya","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024577116","display_name":"Hertzel C. Gerstein","orcid":"https://orcid.org/0000-0001-8072-2836","observed_orcids":["https://orcid.org/0000-0001-8072-2836"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hertzel C. Gerstein","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5055443598","display_name":"Mark C Lakshmanan","orcid":"https://orcid.org/0000-0002-6578-9570","observed_orcids":["https://orcid.org/0000-0002-6578-9570"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark C. Lakshmanan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.8070999979972839,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.8070999979972839,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.16609999537467957,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.006599999964237213,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9100000262260437},{"id":"https://openalex.org/keywords/diabetic-retinopathy","display_name":"diabetic retinopathy","score":0.996999979019165},{"id":"https://openalex.org/keywords/hba1c-reduction","display_name":"HbA1c reduction","score":0.8410000205039978},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9300000071525574},{"id":"https://openalex.org/keywords/cardiovascular-outcome-trials","display_name":"cardiovascular outcome trials","score":0.8299999833106995},{"id":"https://openalex.org/keywords/systolic-blood-pressure","display_name":"systolic blood pressure","score":0.8740000128746033},{"id":"https://openalex.org/keywords/weight","display_name":"weight","score":0.4580000042915344},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.40799999237060547},{"id":"https://openalex.org/keywords/retinopathy-risk","display_name":"retinopathy risk","score":0.8539999723434448}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7000768780708313},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6366417407989502},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.5148562788963318},{"id":"https://openalex.org/C2779829184","wikidata":"https://www.wikidata.org/wiki/Q631361","display_name":"Diabetic retinopathy","level":3,"score":0.51328444480896},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.5091120600700378},{"id":"https://openalex.org/C2778313320","wikidata":"https://www.wikidata.org/wiki/Q550455","display_name":"Retinopathy","level":3,"score":0.47627586126327515},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.45636340975761414},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.451845645904541},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.4462406635284424},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.41585206985473633},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.41156139969825745},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.33032941818237305},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.2027127742767334},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2337/figshare.13100045","doi":"https://doi.org/10.2337/figshare.13100045","is_oa":true,"landing_page_url":"https://doi.org/10.2337/figshare.13100045","pdf_url":"https://diabetesjournals.figshare.com/articles/figure/HbA1c_Change_and_Diabetic_Retinopathy_During_GLP-1_Receptor_Agonist_Cardiovascular_Outcome_Trials_A_Meta-analysis_and_Meta-regression/13100045/1/files/25108103.pdf","source":null,"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.2337/figshare.13100045","doi":"https://doi.org/10.2337/figshare.13100045","is_oa":true,"landing_page_url":"https://doi.org/10.2337/figshare.13100045","pdf_url":"https://diabetesjournals.figshare.com/articles/figure/HbA1c_Change_and_Diabetic_Retinopathy_During_GLP-1_Receptor_Agonist_Cardiovascular_Outcome_Trials_A_Meta-analysis_and_Meta-regression/13100045/1/files/25108103.pdf","source":null,"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4245225751.pdf","grobid_xml":"https://content.openalex.org/works/W4245225751.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3035210110","https://openalex.org/W4221046685","https://openalex.org/W4393252166","https://openalex.org/W4390737456","https://openalex.org/W4313220137","https://openalex.org/W4211100132","https://openalex.org/W4283816664","https://openalex.org/W4384469967","https://openalex.org/W4402878801","https://openalex.org/W7172164892"],"abstract_inverted_index":{"Background:":[0],"Long-term":[1],"glycemic":[2,264],"control":[3,14,265],"reduces":[4],"retinopathy":[5,26,40,70,110,133,185,201,232,247,267],"risk,":[6],"but":[7,22,144,258],"transient":[8],"worsening":[9],"can":[10],"occur":[11],"with":[12,119,176,230,246,251],"glucose":[13],"intensification.":[15],"GLP-1":[16],"receptor":[17],"agonists":[18],"(RA)":[19],"lower":[20],"glucose,":[21],"long-term":[23,35,260],"impact":[24,261],"on":[25,266],"is":[27,216,268],"unknown.":[28],"GLP-1RA":[29,57,66,107,237],"cardiovascular":[30,255],"outcome":[31],"trials":[32],"(CVOTs)":[33],"provide":[34],"follow-up,":[36,192],"allowing":[37],"examination":[38],"of":[39,213,222,241,262],"outcomes.":[41,71],"Purpose:":[42],"To":[43],"examine":[44],"the":[45,139,187,220,259],"associations":[46],"between":[47,106,122,132],"retinopathy,":[48],"HbA1c,":[49,85],"systolic":[50],"blood":[51],"pressure":[52],"(SBP)":[53],"and":[54,87,109,134,162,190,203,208,253],"weight":[55,88],"in":[56,171,205,234,249,270],"CVOTs.":[58,238],"Data":[59,83,97],"Sources:":[60],"Systematic":[61],"review":[62],"identified":[63],"6":[64],"placebo-controlled":[65],"CVOTs":[67,195],"reporting":[68],"prespecified":[69],"Study":[72],"Selection:":[73],"Published":[74],"trial":[75],"reports":[76],"were":[77,95,196],"used":[78],"as":[79],"primary":[80],"data":[81,89],"sources.":[82],"Extraction:":[84],"SBP,":[86],"throughout":[90],"follow-up":[91,141,212],"by":[92],"treatment":[93,108],"group":[94],"extracted.":[96],"Synthesis:":[98],"Random":[99],"effects":[100],"model":[101],"meta-analysis":[102],"showed":[103,129,155],"no":[104,145],"association":[105,131],"(odds":[111],"ratio":[112],"[OR]":[113],"1.10;":[114],"95%":[115],"CI":[116],"0.93,":[117],"1.30),":[118],"high":[120],"heterogeneity":[121],"studies":[123],"(I2=52.2%;":[124],"Q-statistic":[125],"p=0.063).":[126],"Univariate":[127],"meta-regression":[128,235],"an":[130],"average":[135],"HbA1c":[136,154,172,225,242],"reduction":[137,173,226,243],"during":[138],"overall":[140,191],"(slope=0.77,":[142],"p=0.007),":[143],"relationship":[146,157],"for":[147,153,184,236],"SBP":[148],"or":[149,179],"weight.":[150],"Sensitivity":[151],"analyses":[152],"a":[156],"at":[158,186],"3":[159],"months":[160],"(p=0.006)":[161],"1":[163],"year":[164],"(p=0.002).":[165],"A":[166],"0.1%":[167],"(1.09":[168],"mmol/mol)":[169],"increase":[170],"was":[174,227,244],"associated":[175,229],"6%,":[177],"14%,":[178],"8%":[180],"increased":[181,231],"ln":[182],"(OR)":[183],"3-month,":[188],"1-year,":[189],"respectively.":[193],"Limitations:":[194],"not":[197],"powered":[198],"to":[199,219],"assess":[200],"outcomes":[202],"differed":[204],"retinopathy-related":[206],"criteria":[207],"methodology.":[209],"The":[210,239],"median":[211],"3.4":[214],"years":[215],"short":[217],"compared":[218],"onset":[221],"retinopathy.":[223],"Conclusions:":[224],"significantly":[228],"risk":[233,248,256],"magnitude":[240],"correlated":[245],"people":[250],"diabetes":[252],"additional":[254],"factors,":[257],"improved":[263],"unmeasured":[269],"these":[271],"studies.":[272],"Retinopathy":[273],"status":[274],"should":[275],"be":[276],"assessed":[277],"when":[278],"intensifying":[279],"glucose-lowering":[280],"therapy.":[281]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2}],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2022-05-12T00:00:00"}